Citadel Advisors’s GH Research GHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,800
Closed -$30.9K 13437
2025
Q1
$30.9K Buy
+2,800
New +$31.3K ﹤0.01% 12793
2024
Q4
Sell
-1,200
Closed -$8.03K 14834
2024
Q3
$8.03K Buy
1,200
+900
+300% +$9.23K ﹤0.01% 13326
2024
Q2
$3.5K Sell
300
-1,800
-86% -$21.6K ﹤0.01% 13592
2024
Q1
$22.4K Buy
+2,100
New +$16.7K ﹤0.01% 12933

Other funds holding GHRS

Citadel Advisors's GHRS Position: Q2 2026 in Review

Citadel Advisors increased its GH Research (GHRS) stake by 31% in Q2 2026, buying an estimated $428K and bringing the position to 85,952 shares worth $2.31M. The position accounts for ﹤0.01% of the portfolio, ranked #6242.

Citadel Advisors first reported a position in GHRS in Q2 2021 and has held it in 19 quarters since. The position peaked at $29.8M in Q4 2021. 63 funds tracked by Wall St. Rank hold GHRS as of Q2 2026.

  • Citadel Advisors held 85,952 shares of GH Research worth $2.31M as of Q2 2026.
  • Citadel Advisors bought 20,488 GH Research shares in Q2 2026, an estimated $428K.
  • GH Research made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #6242 holding.
  • Citadel Advisors first reported a position in GH Research in Q2 2021 and has held it in 19 quarters since.
  • Citadel Advisors's GH Research position peaked at $29.8M in Q4 2021.
  • 63 funds tracked by Wall St. Rank held GH Research as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.